The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations.
Several COVID-19 vaccines have been approved and administered to millions of people around the globe. Since the virus’s arrival, researchers also have been on the hunt for drugs that can effectively battle the disease in patients that receive a positive diagnosis.
Berg, a company that uses proprietary artificial intelligence (AI) tech to identify and pursue potential drug candidates, recently used its proprietary AI model to pinpoint drugs that could be repurposed to combat the numerous COVID-19 variants that have popped up around the world.